Endonovo Therapeutics Announces Effective Date of Previously Announced Reverse Split of Common Stock
19. Dezember 2019 18:24 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), announced today that its previously announced 1-for-1,000 reverse split of...